Keryx announces new name, new safety data for kidney disease drug

Shares in Keryx Biopharmaceuticals popped today after it published additional data that bolsters the safety profile of its recently approved drug for patients with chronic kidney disease, despite the Food and Drug Administration's labeling on the drug as potentially causing a buildup of iron in the body...